The Filings Report

Texas Instruments

TXNNasdaqCIK 97476Technology / Semiconductorsfiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$6.1B
+27.7% on Q3 FY2025
Net income
$2.4B
+77.8% on Q3 FY2025
Free cash flow
$3.0B
+197.7% on Q3 FY2025
Diluted EPS
$2.62
+77.0% on Q3 FY2025
Revenue, TTM
$20.8B
trailing four quarters
Net margin, TTM
34.3%
net income $7.1B
Free cash flow, TTM
$7.3B
$9.9B less $2.6B capex
Cash and equivalents
$4.2B
long-term debt $12.9B, Sep 30, 2026
Shares, 12-month change
+0.6%
914M shares, Sep 30, 2026
Buybacks, TTM
$636M
0.2% of market value
Dividends, TTM
$5.2B
1.9% of market value
Market value
$274.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 23, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Texas Instruments reported revenue of $6.1B, +27.7% on Q3 FY2025, and net income of $2.4B (+77.8%). Operating margin was 47.5%. Free cash flow, operating cash flow less capital expenditures, was $3.0B ($3.4B less $463M). Diluted earnings per share were $2.62.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 23, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6B$8BQ4'22, Revenue: $4.7BQ4'22, Net income: $2.0BQ4'22Q1'23, Revenue: $4.4BQ1'23, Net income: $1.7BQ1'23Q2'23, Revenue: $4.5BQ2'23, Net income: $1.7BQ2'23Q3'23, Revenue: $4.5BQ3'23, Net income: $1.7BQ3'23Q4'23, Revenue: $4.1BQ4'23, Net income: $1.4BQ4'23Q1'24, Revenue: $3.7BQ1'24, Net income: $1.1BQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $4.2BQ3'24, Net income: $1.4BQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: $1.2BQ4'24Q1'25, Revenue: $4.1BQ1'25, Net income: $1.2BQ1'25Q2'25, Revenue: $4.4BQ2'25, Net income: $1.3BQ2'25Q3'25, Revenue: $4.7BQ3'25, Net income: $1.4BQ3'25Q4'25, Revenue: $4.4BQ4'25, Net income: $1.2BQ4'25Q1'26, Revenue: $4.8BQ1'26, Net income: $1.5BQ1'26Q2'26, Revenue: $5.5BQ2'26, Net income: $2.0BQ2'26Q3'26, Revenue: $6.1BQ3'26, Net income: $2.4BQ3'26$0$2B$4B$6B$8BQ4'22, Revenue: $4.7BQ4'22, Net income: $2.0BQ1'23, Revenue: $4.4BQ1'23, Net income: $1.7BQ1'23Q2'23, Revenue: $4.5BQ2'23, Net income: $1.7BQ3'23, Revenue: $4.5BQ3'23, Net income: $1.7BQ3'23Q4'23, Revenue: $4.1BQ4'23, Net income: $1.4BQ1'24, Revenue: $3.7BQ1'24, Net income: $1.1BQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $1.1BQ3'24, Revenue: $4.2BQ3'24, Net income: $1.4BQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: $1.2BQ1'25, Revenue: $4.1BQ1'25, Net income: $1.2BQ1'25Q2'25, Revenue: $4.4BQ2'25, Net income: $1.3BQ3'25, Revenue: $4.7BQ3'25, Net income: $1.4BQ3'25Q4'25, Revenue: $4.4BQ4'25, Net income: $1.2BQ1'26, Revenue: $4.8BQ1'26, Net income: $1.5BQ1'26Q2'26, Revenue: $5.5BQ2'26, Net income: $2.0BQ3'26, Revenue: $6.1BQ3'26, Net income: $2.4BQ3'26

Net income losses drawn in red.

Free cash flow
−$1B$0$1B$2B$3BQ4'22, Free cash flow: $1.1BQ4'22Q1'23, Free cash flow: $178MQ1'23Q2'23, Free cash flow: −$47MQ2'23Q3'23, Free cash flow: $442MQ3'23Q4'23, Free cash flow: $776MQ4'23Q1'24, Free cash flow: −$231MQ1'24Q2'24, Free cash flow: $507MQ2'24Q3'24, Free cash flow: $416MQ3'24Q4'24, Free cash flow: $806MQ4'24Q1'25, Free cash flow: −$274MQ1'25Q2'25, Free cash flow: $555MQ2'25Q3'25, Free cash flow: $993MQ3'25Q4'25, Free cash flow: $1.3BQ4'25Q1'26, Free cash flow: $844MQ1'26Q2'26, Free cash flow: $2.2BQ2'26Q3'26, Free cash flow: $3.0BQ3'26−$1B$0$1B$2B$3BQ4'22, Free cash flow: $1.1BQ1'23, Free cash flow: $178MQ1'23Q2'23, Free cash flow: −$47MQ3'23, Free cash flow: $442MQ3'23Q4'23, Free cash flow: $776MQ1'24, Free cash flow: −$231MQ1'24Q2'24, Free cash flow: $507MQ3'24, Free cash flow: $416MQ3'24Q4'24, Free cash flow: $806MQ1'25, Free cash flow: −$274MQ1'25Q2'25, Free cash flow: $555MQ3'25, Free cash flow: $993MQ3'25Q4'25, Free cash flow: $1.3BQ1'26, Free cash flow: $844MQ1'26Q2'26, Free cash flow: $2.2BQ3'26, Free cash flow: $3.0BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $3.0BQ4'22, Long-term debt: $8.2BQ4'22Q1'23, Cash and equivalents: $4.5BQ1'23, Long-term debt: $9.6BQ1'23Q2'23, Cash and equivalents: $3.4BQ2'23, Long-term debt: $10.9BQ2'23Q3'23, Cash and equivalents: $2.6BQ3'23, Long-term debt: $10.9BQ3'23Q4'23, Cash and equivalents: $3.0BQ4'23, Long-term debt: $10.6BQ4'23Q1'24, Cash and equivalents: $2.5BQ1'24, Long-term debt: $12.8BQ1'24Q2'24, Cash and equivalents: $2.7BQ2'24, Long-term debt: $12.8BQ2'24Q3'24, Cash and equivalents: $2.6BQ3'24, Long-term debt: $12.8BQ3'24Q4'24, Cash and equivalents: $3.2BQ4'24, Long-term debt: $12.8BQ4'24Q1'25, Cash and equivalents: $2.8BQ1'25, Long-term debt: $12.8BQ1'25Q2'25, Cash and equivalents: $3.0BQ2'25, Long-term debt: $14.0BQ2'25Q3'25, Cash and equivalents: $3.3BQ3'25, Long-term debt: $13.5BQ3'25Q4'25, Cash and equivalents: $3.2BQ4'25, Long-term debt: $13.5BQ4'25Q1'26, Cash and equivalents: $3.5BQ1'26, Long-term debt: $12.9BQ1'26Q2'26, Cash and equivalents: $3.7BQ2'26, Long-term debt: $12.9BQ2'26Q3'26, Cash and equivalents: $4.2BQ3'26, Long-term debt: $12.9BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $3.0BQ4'22, Long-term debt: $8.2BQ1'23, Cash and equivalents: $4.5BQ1'23, Long-term debt: $9.6BQ1'23Q2'23, Cash and equivalents: $3.4BQ2'23, Long-term debt: $10.9BQ3'23, Cash and equivalents: $2.6BQ3'23, Long-term debt: $10.9BQ3'23Q4'23, Cash and equivalents: $3.0BQ4'23, Long-term debt: $10.6BQ1'24, Cash and equivalents: $2.5BQ1'24, Long-term debt: $12.8BQ1'24Q2'24, Cash and equivalents: $2.7BQ2'24, Long-term debt: $12.8BQ3'24, Cash and equivalents: $2.6BQ3'24, Long-term debt: $12.8BQ3'24Q4'24, Cash and equivalents: $3.2BQ4'24, Long-term debt: $12.8BQ1'25, Cash and equivalents: $2.8BQ1'25, Long-term debt: $12.8BQ1'25Q2'25, Cash and equivalents: $3.0BQ2'25, Long-term debt: $14.0BQ3'25, Cash and equivalents: $3.3BQ3'25, Long-term debt: $13.5BQ3'25Q4'25, Cash and equivalents: $3.2BQ4'25, Long-term debt: $13.5BQ1'26, Cash and equivalents: $3.5BQ1'26, Long-term debt: $12.9BQ1'26Q2'26, Cash and equivalents: $3.7BQ2'26, Long-term debt: $12.9BQ3'26, Cash and equivalents: $4.2BQ3'26, Long-term debt: $12.9BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 23, 2026.

Texas Instruments income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 23, 2026Q2 FY2026ended Jun 30, 2026filed Jul 24, 2026Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue6,0555,4634,8254,4234,7424,4484,0694,007+27.7%
Cost of revenue2,1682,1112,0261,9512,0191,8731,7561,693+7.4%
Gross profit3,8873,3522,7992,4722,7232,5752,3132,314+42.7%
Research and development530535510521518527517491+2.3%
Selling, general and administrative476490464446457485472446+4.2%
Operating income2,8742,3101,8081,4731,6631,5631,3241,377+72.8%
Other income (expense)72694740624880112+16.1%
Pretax income2,8052,2381,7141,3721,5841,4781,2761,359+77.1%
Income tax38025816920922018397154+72.7%
Net income2,4251,9801,5451,1631,3641,2951,1791,205+77.8%
Diluted EPS ($)2.622.141.68—1.481.411.28—+77.0%
Diluted shares (millions)921920914—914912916——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 23, 2026.

Texas Instruments balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 23, 2026Q2 FY2026ended Jun 30, 2026filed Jul 24, 2026Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents4,2113,6603,5493,2253,3113,0442,7633,200+27.2%
Short-term investments3,9313,3411,5541,6561,8752,3152,2424,380+109.7%
Total current assets16,88015,75713,79613,75013,87614,48413,08615,026+21.6%
Total assets36,83935,88234,39334,58535,00434,93333,75735,509+5.2%
Total current liabilities3,0173,2443,0963,1593,1182,4922,4893,643−3.2%
Long-term debt12,90512,90312,90113,54813,54614,04312,84812,846−4.7%
Total liabilities17,65417,87517,61518,31218,37718,53017,35118,606−3.9%
Stockholders’ equity19,18518,00716,77816,27316,62716,40316,40616,903+15.4%
Shares outstanding (millions)914913910908909909908910—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 23, 2026.

Texas Instruments cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 23, 2026Q2 FY2026ended Jun 30, 2026filed Jul 24, 2026Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026Q4 FY2025ended Dec 31, 2025filed Feb 6, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow3,4192,7031,5202,2542,1901,8608491,998+56.1%
Capital expenditures4635146769251,1971,3051,1231,192−61.3%
Free cash flow (CFO − capex)2,9562,1898441,329993555(274)806+197.7%
Depreciation and amortization—————————
Share repurchases4827158403119302653537−59.7%
Dividends paid1,2981,2951,2911,2901,2361,2351,2381,240+5.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 6, 2026.

Income statement

Texas Instruments income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 6, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 2, 2024FY2022ended Dec 31, 2022filed Feb 3, 2023FY2021ended Dec 31, 2021filed Feb 4, 2022FY2020ended Dec 31, 2020filed Feb 5, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 24, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Revenue17,68215,64117,51920,02818,34414,46114,38315,78414,96113,37013,00013,04512,20512,82513,73513,96610,42712,50113,835
Cost of revenue7,5996,5476,5006,2575,9685,1925,2195,5075,3475,1135,4255,6185,8416,4576,9636,4745,4286,2566,466
Gross profit10,0839,09411,01913,77112,3769,2699,16410,2779,6148,2577,5757,4276,3646,3686,7727,4924,9996,2457,369
Research and development2,0831,9591,8631,6701,5541,5301,5441,5591,5081,3561,2671,3581,5221,8771,7151,5701,4761,9402,140
Selling, general and administrative1,8601,7941,8251,7041,6661,6231,6451,6841,6941,7421,7281,8431,8581,8041,6381,5191,3201,6141,680
Operating income6,0235,4657,33110,1408,9605,8945,7236,7136,0834,8554,3223,9472,8321,9732,9924,5141,9912,4373,497
Other income (expense)2304964401061433131759875155(16)2117475372644195
Pretax income5,7105,4537,41810,0328,9196,0175,7286,6866,0804,9304,2163,8742,7541,9352,9554,5512,0172,4813,692
Income tax7096549081,2831,1504227111,1062,3981,3351,2301,0535921767191,3235475611,051
Net income5,0014,7996,5108,7497,7695,5955,0175,5803,6823,5952,9862,8212,1621,7592,2363,2281,4701,9202,657
Diluted EPS ($)5.455.207.079.418.265.975.245.593.613.482.822.571.911.511.882.621.151.441.83
Diluted shares (millions)9139199169269369339529901,0121,0211,0431,0801,1131,1461,1711,2131,2691,3211,444

Balance sheet

Texas Instruments balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 6, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 2, 2024FY2022ended Dec 31, 2022filed Feb 3, 2023FY2021ended Dec 31, 2021filed Feb 4, 2022FY2020ended Dec 31, 2020filed Feb 5, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 24, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Cash and equivalents3,2253,2002,9643,0504,6313,1072,4372,4381,6561,1541,0001,1991,6271,4169921,3191,1821,0461,328
Short-term investments1,6564,3805,6116,0175,1083,4612,9501,7952,8132,3362,2182,3422,2022,5491,9431,7531,7431,494—
Total current assets13,75015,02615,12214,02113,68510,2398,7618,0978,7347,4577,0747,4218,0198,2307,8287,0606,1145,790—
Total assets34,58535,50932,34827,20724,67619,35118,01817,13717,64216,43116,23017,37218,93820,02120,49713,40112,11911,923—
Total current liabilities3,1593,6433,3202,9852,5692,3902,1232,4742,2582,2642,5552,6582,7473,4303,4991,9811,5871,532—
Long-term debt13,54812,84610,6248,2357,2416,2485,3034,3193,5772,9783,1203,6304,1584,1864,2110———
Total liabilities18,31218,60615,45112,63011,34310,1649,1118,1437,3055,9586,2846,9828,1319,0609,5452,9642,3972,597—
Stockholders’ equity16,27316,90316,89714,57713,3339,1878,9078,99410,33710,4739,94610,39010,80710,96110,95210,4379,7229,326—
Shares outstanding (millions)9089109099069249209349389841,0001,0051,0471,0841,1051,1451,1721,242——

Cash flow statement

Texas Instruments cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 6, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 2, 2024FY2022ended Dec 31, 2022filed Feb 3, 2023FY2021ended Dec 31, 2021filed Feb 4, 2022FY2020ended Dec 31, 2020filed Feb 5, 2021FY2019ended Dec 31, 2019filed Feb 20, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 23, 2017FY2015ended Dec 31, 2015filed Feb 24, 2016FY2014ended Dec 31, 2014filed Feb 24, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Operating cash flow7,1536,3186,4208,7208,7566,1396,6497,1895,3634,614—————————
Capital expenditures4,5504,8205,0712,7972,4626498471,1316955315513854124958161,199753763686
Free cash flow (CFO − capex)2,6031,4981,3495,9236,2945,4905,8026,0584,6684,083—————————
Depreciation and amortization———————————————————
Share repurchases1,4779292933,6155272,5532,9605,1002,5562,1322,7412,8312,8681,8001,9732,454———
Dividends paid4,9994,7954,5574,2973,8863,4263,0082,5552,1041,6461,4441,3231,175819644592567537425

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$8M
8 sales by 5 insiders; officers and directors $8M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$125M
52 sales by 21 insiders; officers and directors $125M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 29, 2026Kirk RonaldDirectoroption exercise6,065$79.26$481K21,527Oct 30, 2026
Oct 29, 2026Kirk RonaldDirectoropen-market sale6,065$310.39$2M15,462Oct 30, 2026
Oct 27, 2026Clark Janet FDirectoroption exercise4,306$110.15$474K15,647Oct 29, 2026
Oct 27, 2026Clark Janet FDirectoropen-market sale3,956$302.40$1M11,691Oct 29, 2026
Oct 27, 2026Clark Janet FDirectoropen-market sale350$303.17$106K11,341Oct 29, 2026
Oct 27, 2026Patsley Pamela HDirectoroption exercise4,532$104.41$473K39,019Oct 29, 2026
Oct 27, 2026Patsley Pamela HDirectoropen-market sale4,532$301.56$1M34,487Oct 29, 2026
Oct 27, 2026Sanchez Robert EDirectoroption exercise6,065$79.26$481K27,665Oct 29, 2026
Oct 27, 2026Sanchez Robert EDirectoropen-market sale5,588$302.14$2M22,077Oct 29, 2026
Oct 27, 2026Sanchez Robert EDirectoropen-market sale477$303.07$145K21,600Oct 29, 2026
Aug 27, 2026Abraham TsedeniyaSr. Vice Presidentoption exercise1,365$79.26$108K30,181Aug 31, 2026
Aug 27, 2026Abraham TsedeniyaSr. Vice Presidentopen-market sale6,408$264.60$2M23,773Aug 31, 2026
Aug 27, 2026Abraham TsedeniyaSr. Vice Presidentopen-market sale592$264.96$157K23,181Aug 31, 2026
Jul 24, 2026Knecht Julie C.VP & Chief Accounting Officeraward7,154$0.00—16,294Jul 31, 2026
May 28, 2026Craighead Martin SDirectoropen-market sale9,643$320.41$3M14,716May 29, 2026
May 28, 2026Craighead Martin SDirectoropen-market sale357$321.01$115K14,359May 29, 2026
May 14, 2026Bahai AhmadSr. Vice Presidentoption exercise5,000$110.15$551K47,519May 15, 2026
May 14, 2026Bahai AhmadSr. Vice Presidentopen-market sale5,000$309.13$2M42,519May 15, 2026
May 14, 2026Lizardi Rafael RSr. Vice President & CFOoption exercise47,734$174.81$8M133,219May 15, 2026
May 14, 2026Lizardi Rafael RSr. Vice President & CFOopen-market sale32,119$307.85$10M101,100May 15, 2026
May 14, 2026Lizardi Rafael RSr. Vice President & CFOopen-market sale14,156$308.54$4M86,944May 15, 2026
May 14, 2026Lizardi Rafael RSr. Vice President & CFOopen-market sale1,459$309.45$451K85,485May 15, 2026
May 13, 2026Cox Carrie SmithDirectoroption exercise4,306$110.15$474K41,932May 14, 2026
May 13, 2026Cox Carrie SmithDirectoroption exercise4,532$104.41$473K46,464May 14, 2026
May 13, 2026Cox Carrie SmithDirectoropen-market sale8,393$306.37$3M38,071May 14, 2026

Full insider history for Texas Instruments, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

2 of the tracked managers held TXN in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded TXN by quarter.

FundManagerQuarterValueSharesWeightMove
FundsmithTerry SmithQ2 2026$536M2M3.93%trimmed −31.4%
Baron Capital GroupRon BaronQ2 2026$15K490.00%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
TEXAS INSTRUMENTS INCORPORATED, CIK 97476 on EDGAR
Extract generated
October 26, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold, CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: not filed
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated October 26, 2026.

JSON file
/data/financials/TXN.json